CGAS and cancer: Interestingly, cGAS/STING can lead to the activation of non-canonical NF-κB signaling without altering IFN signaling, indicating that cancer cells can eschew type I IFN signaling while benefiting from cGAS/STING-induced pro-tumor inflammation (62, 131).